Consistent with these in vitro findings, CD8+ T cells isolated from the ascites of HGSOC patients demonstrated a significant reduction in surface FABP5 expression compared with peripheral CD8+ T cells from cancer-free women (Fig. 1g), although their total FABP5 levels were comparable (Fig. 1h). This evidence concerns the gene FABP5 and cancer.